Human herpesvirus 6 viremia in bone marrow transplant recipients: clinical features and risk factors. - Wikidata - wikimedia - TriplyDB

Human herpesvirus 6 viremia in bone marrow transplant recipients: clinical features and risk factors.

Human herpesvirus 6 viremia in bone marrow transplant recipients: clinical features and risk factors.

http://www.wikidata.org/entity/Q45124793

about

Antiviral agents for prophylaxis of herpesviridae infections in patients with haematological malignancies Antiviral agents for prophylaxis of herpesviridae infections in patients with haematological malignancies Update on human herpesvirus 6 biology, clinical features, and therapy Human herpesvirus 6 infection in hematopoietic stem cell transplant patients HHV-6 reactivation and associated sequelae after hematopoietic cell transplantation Diagnostic Clues to Human Herpesvirus 6 Encephalitis and Wernicke Encephalopathy After Pediatric Hematopoietic Cell Transplantation.Human herpesvirus 6A (HHV-6A) and HHV-6B alter E2F1/Rb pathways and E2F1 localization and cause cell cycle arrest in infected T cells Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals.Human Herpesvirus-6 Pneumonitis around the Engraftment of Cord Blood Transplantation following Foscarnet Prophylaxis in a Patient with Acute Leukemia.Human herpesvirus 6: relevance of infection in the immunocompromised host.Analysis of ganciclovir-resistant human herpesvirus 6B clinical isolates using quenching probe PCR methodology.Rapid diagnosis of human herpesvirus 6 infection by a novel DNA amplification method, loop-mediated isothermal amplification.Human herpesvirus 6 infection after hematopoietic cell transplantation: is routine surveillance necessary?A Simple Proteomics-Based Approach to Identification of Immunodominant Antigens from a Complex Pathogen: Application to the CD4 T Cell Response against Human Herpesvirus 6B Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation.Beta-herpesviruses in febrile children with cancer Prevalence of human herpesvirus 6 antibodies and DNA in allogeneic stem cell transplant patients: two-year single centre experience.Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis.Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation.Copy numbers of telomeric repeat sequences of human herpesvirus 6B in clinical isolates: possibility of mixed infections.Contemporary infectious exanthems: an update.Analysis of human herpes virus 6 infections with a quantitative, standardized, commercial kit in pediatric stem cell transplant recipients after transplantation.Virus reactivations after autologous hematopoietic stem cell transplantation detected by multiplex PCR assay.Cycling probe-based real-time PCR for the detection of Human herpesvirus 6A and B.Early human herpes virus type 6 reactivation in umbilical cord blood allogeneic stem cell transplantation.Human herpesvirus-6 viremia is not associated with poor clinical outcomes in children following allogeneic hematopoietic cell transplantation.Virological analysis of inherited chromosomally integrated human herpesvirus-6 in three hematopoietic stem cell transplant patients.Neurocognitive Dysfunction in Hematopoietic Cell Transplant Recipients: Expert Review From the Late Effects and Quality of Life Working Committee of the CIBMTR and Complications and Quality of Life Working Party of the EBMT.Human herpesvirus type 6 DNAemia and infection following allogeneic stem cell transplantation with a focus on long-term outcome.Human herpesvirus 6 antigenaemia in allogeneic stem cell transplant recipients: impact on clinical course and association with other beta-herpesviruses.Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study.Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT.Development of a microwell adapted immunoblot system with recombinant antigens for distinguishing human herpesvirus (HHV)6A and HHV6B and detection of human cytomegalovirus.Rare viral infections in children receiving hemopoietic stem cell transplant.High incidence of cytomegalovirus, human herpesvirus-6, and Epstein-Barr virus reactivation in patients receiving cytotoxic chemotherapy for adult T cell leukemia.Myelitis associated with human herpes virus 6 (HHV-6) after allogeneic cord blood transplantation.Risk factors of human herpesvirus 6 encephalitis/myelitis after allogeneic hematopoietic stem cell transplantation.Correlations of HHV-6 viral load and plasma IL-6 concentration with HHV-6 encephalitis in allogeneic stem cell transplant recipients.Atypical exanthems related to human herpesvirus-6 reactivations in transplant recipients.Development of quantitative RT-PCR assays for detection of three classes of HHV-6B gene transcripts.

P2860

Q24234350-ED4591C4-12CF-423B-8857-72F5BFA22CDF Q24241918-8D15159E-24F3-4055-8D78-4E99FFF480F9 Q24557543-EE917393-DFCA-43C0-9C58-A92C533F848A Q28246906-96713B3B-FB1F-44CF-A2AD-91DB21AE8A02 Q28727925-F6837D09-988F-4870-9118-1CD5EFE1FC0A Q30883059-BFFDCC87-27F6-471B-B830-AC195DE2E305 Q33301426-F264A6F3-F21D-4666-A018-D0C62A7EC7C0 Q34537814-94AE30BC-BC93-4533-AF50-FC7548D2A627 Q35012438-40D400D2-DD56-4C39-9D37-2D4B531EBDEB Q35064314-06980435-AB16-4606-86BC-7D03837B5651 Q35385659-7EE82BD9-E85D-4AF7-B390-213C244FEE25 Q35551852-9B2E6DCA-FE2D-4D3D-8AC6-0D1F6674ED11 Q35774717-7CB922C1-C1E1-4994-9094-9A3E9D63FEB9 Q35850475-5F07F2D5-8452-4006-9C04-E87FB03E01F2 Q36095851-9D614010-DBAD-4537-B974-D0450BD82F47 Q36944956-A6003543-BB67-4605-9034-44E864DBA881 Q37177116-C92262E2-5DB1-4E4A-8C3F-453B279159C1 Q37276889-257B9494-6FBB-49A6-AB80-BE341137D97E Q37426542-C9C9BB64-D5EC-4308-9A2C-FE04BC446835 Q37546237-18598722-CD38-408B-8425-E3421D88F3A8 Q38795858-25066D32-3AE3-4817-B53D-33592309D8D7 Q40213229-221E10FB-501C-4073-900C-0DC4B5301AEA Q40629756-3A4730EC-AB87-4859-8F58-B0203D445BD6 Q40766749-81CF64BE-D773-4DBC-9F3E-0B48B949729A Q40849677-8A0F17EA-E272-45CD-9195-FDBAFD9495A9 Q41021152-86E2037D-9BCA-485F-A4EF-F3284E6BBD73 Q41585310-B05ABE71-08DE-4485-9468-1C95847F70F3 Q41995096-8A1C079A-1B75-4E91-B1C1-4BBE6538691A Q42272500-07B905F7-B6BF-4EF2-9EB0-F182F555FFA7 Q43636855-0FE871B7-CAFC-4E49-9C4E-92FD4ECC7E7F Q43971471-1934E2BF-3F5C-4679-8EA9-247EB0710610 Q44189939-0B89B2B0-633D-4739-8D04-6224A81797D7 Q44356190-B9F5A8C1-C2B3-4443-86A3-3E92B53ED50B Q44920798-694328D6-29E2-483E-AEC5-4CEC9CF57213 Q45368979-7146E768-993B-474D-8BDF-F8078E23F76A Q45406137-D7754168-4E48-4B56-9837-DC29B95A91C6 Q47436824-F607B14C-03C0-4C92-9280-C16C2494CABA Q47733733-3BA3686A-AC9F-4128-B207-25B31A43ECA0 Q50863623-F9B2FE15-445A-42CA-A4A6-905B53C6813A Q54299593-89538CB7-25E1-4431-9383-09C287B805E5

P2860

Human herpesvirus 6 viremia in bone marrow transplant recipients: clinical features and risk factors.

http://www.wikidata.org/entity/Q45124793

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Human herpesvirus 6 viremia in ...... cal features and risk factors.

@en

Human herpesvirus 6 viremia in ...... cal features and risk factors.

@nl

type

label

Human herpesvirus 6 viremia in ...... cal features and risk factors.

@en

Human herpesvirus 6 viremia in ...... cal features and risk factors.

@nl

prefLabel

Human herpesvirus 6 viremia in ...... cal features and risk factors.

@en

Human herpesvirus 6 viremia in ...... cal features and risk factors.

@nl

P1433

Q45124793-2D3B1427-C883-45C2-A15D-5F8072FC1DD9

P1476

Q45124793-9EF9DB81-C59B-49F1-960B-9E6765DED076

P2093

Q45124793-192E9E0E-D8AD-47AC-908F-B35CC262C780

Q45124793-1E549E59-A0CB-4D68-B0A4-1ABCA19C7D30

Q45124793-3CD83D4C-6379-4E6A-A9C7-7BA388BA2F0F

Q45124793-4E560D55-BF9D-4797-A63E-7D0686B4F6DF

Q45124793-6228292E-25FE-4A95-939B-82B21CDC4A35

Q45124793-62A5410B-C628-4951-B14C-3D19AB9500DC

Q45124793-8B1C364A-C69C-4CA2-BB42-624889EE7D43

Q45124793-94E6F243-7A83-4F5C-A2E2-30E80029DDA5

Q45124793-ADF73A60-2BFC-4424-85EE-AD2A350C1800

Q45124793-D10FF6B3-4B01-4E54-B0C7-399647A3EDE3

P304

Q45124793-6E3B1D34-1428-47B8-8E35-D7A9CD7B11B4

P31

Q45124793-8A35D440-C77B-4C8D-8DA2-517F88CC43B3

P356

Q45124793-83B5FBC2-5C17-476C-B4C8-BD239241D46B

P407

Q45124793-0CD9518D-4EF9-4CE1-B2B3-59EA809F2F76

P433

Q45124793-1FB40055-6D1E-44FD-ADC4-CA8176C937D3

P478

Q45124793-E155CCD1-30FB-4311-BD0A-92F8A43AF0E9

P577

Q45124793-A23B898A-5B46-424C-8E72-A75F80BDF92C

P5875

Q45124793-BEC2EE84-F993-43E2-98CE-669F4AD4B701

P698

Q45124793-F97D7B22-D460-47D2-9E0E-59BF807B1FDC

P921

Q45124793-736774B9-FD1F-4F84-B385-55A0FAB9BD05

P356

P1433

The Journal of Infectious Diseases

P1476

Human herpesvirus 6 viremia in ...... cal features and risk factors.

@en

P2093

Kazuko Kudo

http://www.w3.org/2001/XMLSchema#string

Keizo Horibe

http://www.w3.org/2001/XMLSchema#string

Koji Kato

http://www.w3.org/2001/XMLSchema#string

Kyoko Suzuki

http://www.w3.org/2001/XMLSchema#string

Masahiro Ohashi

http://www.w3.org/2001/XMLSchema#string

Masaru Ihira

http://www.w3.org/2001/XMLSchema#string

Sadao Suga

http://www.w3.org/2001/XMLSchema#string

Seiji Kojima

http://www.w3.org/2001/XMLSchema#string

Takaharu Matsuyama

http://www.w3.org/2001/XMLSchema#string

Tetsushi Yoshikawa

http://www.w3.org/2001/XMLSchema#string

P304

847-853

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/339411

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

185

http://www.w3.org/2001/XMLSchema#string

P577

2002-03-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11445050

http://www.w3.org/2001/XMLSchema#string

P698

11920307

http://www.w3.org/2001/XMLSchema#string

P921